| Zacks Company Profile for ICU Medical, Inc. (ICUI : NSDQ) |
|
|
| |
| • Company Description |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Number of Employees: 15,000 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $137.26 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 209,695 shares |
| Shares Outstanding: 24.61 (millions) |
| Market Capitalization: $3,378.24 (millions) |
| Beta: 0.87 |
| 52 Week High: $196.26 |
| 52 Week Low: $117.92 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
3.69% |
-0.20% |
| 12 Week |
-1.02% |
-16.74% |
| Year To Date |
-11.54% |
-17.16% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
951 CALLE AMANECER
-
SAN CLEMENTE,CA 92763
USA |
ph: 949-366-2183
fax: 949-366-8368 |
ir@icumed.com |
http://www.icumed.com |
|
|
| |
| • General Corporate Information |
Officers
Vivek Jain - Chief Executive Officer and Chairman of the Board
Daniel Woolson - President
Christian Voigtlander - Chief Operating Officer
Brian Bonnell - Chief Financial Officer and Treasurer
Virginia Sanzone - Corporate Vice President; General Counsel
|
|
Peer Information
ICU Medical, Inc. (BJCT)
ICU Medical, Inc. (CADMQ)
ICU Medical, Inc. (APNO)
ICU Medical, Inc. (UPDC)
ICU Medical, Inc. (IMTIQ)
ICU Medical, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 44930G107
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
|
|
Share - Related Items
Shares Outstanding: 24.61
Most Recent Split Date: 3.00 (1.50:1)
Beta: 0.87
Market Capitalization: $3,378.24 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $1.20 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $5.40 |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/06/25 |
|
|
|
| |
